Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA for high-risk HPV infection and cervical intraepithelial neoplasia (Phase II, single-arm)
CTR20140770Phase 2Completed
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on CTR20140770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140770.